109
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk

, , , , &
Pages 733-745 | Published online: 08 Nov 2018

References

  • OsnabruggeRLMylotteDHeadSJAortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling studyJ Am Coll Cardiol201362111002101223727214
  • JohnstonLEDownsEAHawkinsRBOutcomes for Low-Risk Surgical Aortic Valve Replacement: A Benchmark for Aortic Valve TechnologyAnn Thorac Surg201710441282128828610884
  • BrennanJMThomasLCohenDJTranscatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched ComparisonJ Am Coll Cardiol201770443945028728688
  • Di EusanioMPhanKSutureless aortic valve replacementAnn Car-diothorac Surg201542123130
  • Carnero-AlcázarMMarotoLCCobiella-CarnicerJTranscatheter versus surgical aortic valve replacement in moderate and high-risk patients: a meta-analysisEur J Cardiothorac Surg201751464465228007879
  • GargARaoSVVisveswaranGTranscatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-AnalysisJ Invasive Cardiol201729620921628570236
  • ReynoldsMRLeiYWangKCost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve ReplacementJ Am Coll Cardiol2016671293826764063
  • TamDYHughesAFremesSEA cost-utility analysis of trans-catheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical riskJ Thorac Cardiovasc Surg201815551978198829454487
  • PradelliLZanioloOPerceval Sutureless valves in isolated and concomitant AVR procedures: an economic model shows overall decrease of costs for isolated or combined operationsFarmeconomia. Health economics and therapeutic pathways2012134159174
  • LabordeFFolliguetTGhorayebGZannisKSutureless Valves Reduce Hospital Costs Compared to Traditional ValvesJ Heart Valve Dis20172611828544824
  • MinamiTSainteSDe PraetereHHospital cost savings and other advantages of sutureless vs stented aortic valves for intermediate-risk elderly patientsSurg Today201747101268127328386747
  • PollariFSantarpinoGDell’AquilaAMBetter short-term outcome by using sutureless valves: a propensity-matched score analysisAnn Thorac Surg201498261161724928678
  • SantarpinoGPfeifferSJesslJClinical Outcome and Cost Analysis of Sutureless Versus Transcatheter Aortic Valve Implantation With Propensity Score Matching AnalysisAm J Cardiol2015116111737174326433277
  • HICPs – Harmonized Indices of Consumer Prices – Health sector [webpage on the Internet] Available from: http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&language=en&pcode=tec00027&plugin=1Accessed December 12, 2017
  • Consumer Price Index (CPI) Australia – Australian Bureau of Statistics Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/DetailsPage/6401.0Sep%202017?OpenDocumentAccessed December 2017
  • National Institute for Health and Care Excellence (NICE)Guide to the methods of technology appraisal 2013 (PMG9) Available from: https://www.nice.org.uk/process/pmg9
  • WendlerOSchymikGTreedeHSOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart ValveCirculation2017135121123113228104716
  • WanXWangWLiuJTongTEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141413525524443
  • TakagiHAndoTUmemotoTALICE (All-Literature Investigation of Cardiovascular Evidence) GroupDirect and adjusted indirect comparisons of perioperative mortality after sutureless or rapid-deployment aortic valve replacement versus transcatheter aortic valve implantationInt J Cardiol201722832733427866023
  • TakagiHUmemotoTALICE (All-Literature Investigation of Cardiovascular Evidence) GroupSutureless aortic valve replacement may improve early mortality compared with transcatheter aortic valve implantation: A meta-analysis of comparative studiesJ Cardiol201667650451226476500
  • MecoMMiceliMMontisciASutureless aortic valve replacement versus transcatheter aortic valve implantation: a meta-analysis of comparative matched studies using propensity score matchingInteractive Cardio Vasc Thorac Surg201718
  • WangNTsaiYCNilesNTranscatheter aortic valve implantation (TAVI) versus sutureless aortic valve replacement (SUAVR) for aortic stenosis: a systematic review and meta-analysis of matched studiesJ Thorac Dis20168113283329328066608
  • UssiaGPBarbantiMPetronioASTranscatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesisEur Heart J201233896997622240494
  • KodaliSKWilliamsMRSmithCRTwo-year outcomes after transcatheter or surgical aortic-valve replacementN Engl J Med Overseas Ed20123661816861695
  • OrlandoRPennantMRooneySCost-effectiveness of transcatheter aortic valve implantation (TAVI) or aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluationHealth Technol Assess20131733186
  • EandiMPradelliLIannazzoSChiroliSPontorieroGEconomic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in ItalyPharmacoeconomics201028111041105420936886
  • BarbantiMPetronioASEttoriF5-Year Outcomes After Trans-catheter Aortic Valve Implantation With CoreValve ProsthesisJACC Cardiovasc Interv2015881084109126117458
  • SantarpinoGPfeifferSJesslJSutureless replacement versus transcatheter valve implantation in aortic valve stenosis: a propensity-matched analysis of 2 strategies in high-risk patientsJ Thorac Cardiovasc Surg2014147256156724280712
  • FischleinTMeurisBHakim-MeibodiKThe sutureless aortic valve at 1 year: A large multicenter cohort studyJ Thorac Cardiovasc Surg201615161617162626936009
  • GöhlerAGeislerBPManneJMUtility estimates for decision-analytic modeling in chronic heart failure – health states based on New York Heart Association classes and number of rehospitalizationsValue Health200912118518718647251
  • CodnerPOrvinKAssaliALong-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve ImplantationAm J Cardiol201511691391139826342515
  • LeonMBSmithCRMackMTranscatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgeryN Engl J Med2010363171597160720961243
  • MeurisBFlamengWJLabordeFFolliguetTAHaverichAShresthaMFive-year results of the pilot trial of a sutureless valveJ Thorac Cardiovasc Surg20151501848825940415
  • ReardonMJAdamsDHKleimanNS2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve ReplacementJ Am Coll Cardiol201566211312126055947
  • SantarpinoGPfeifferSConcistrèGFischleinTPerceval sutureless aortic valve prosthesis: easy, fast, and safeInnovations20116637838122436773
  • NeriLMcewanPSennfältKBaboolalKCharacterizing the relationship between health utility and renal function after kidney transplantation in UK and US: a cross-sectional studyHealth Qual Life Outcomes20121013923173709
  • ChevreulKBrunnMCadierBCost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registryArch Cardiovasc Dis2013106420921923706367
  • New and emerging cardiac technologies in Australian and New Zealand public health services over the next decade [webpage on the Internet]DLA Piper Australia2013 Available from: http://thehub.superu.govt.nz/sites/default/files/43019_DLA_Cardiac_Report_0.pdfAccessed December 12th, 2017
  • ShresthaMFischleinTMeurisBEuropean multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patientsEur J Cardiothorac Surg201649123424125750010
  • AilawadiGLaparDJSpeirAMContemporary Costs Associated With Transcatheter Aortic Valve Replacement: A Propensity-Matched Cost AnalysisAnn Thorac Surg2016101115416126409710
  • LindsayACSriharanMLazouraOClinical and economic consequences of non-cardiac incidental findings detected on cardiovascular computed tomography performed prior to transcatheter aortic valve implantation (TAVI)Int J Cardiovasc Imaging20153171435144626068211
  • RossiADe CeccoCNKennonSROCT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacementJ Cardiovasc Comput Tomogr201711533834628662835
  • MwipatayiBPPicardoAMasilonyane-JonesTVIncidence and prognosis of vascular complications after transcatheter aortic valve implantationJ Vasc Surg20135841028103623993436
  • PaoneSMiglioreAAbrahaIwebpage on the InternetSutureless aortic valve replacement for aortic valve stenosisRome2015 Available from: http://www.salute.gov.it/imgs/C_17_pagineAree_1202_lista-File_itemName_9_file.pdfAccessed December 12th, 2017
  • Australian Prostheses List (PLAC) [webpage on the Internet] Available from: http://www.health.gov.au/internet/main/publishing.nsf/content/health-about-PLACAccessed December 12th, 2017
  • New Technology Add-On Payment (NTAP) for Perceval [webpage on the Internet] Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/FY2018-IPPS-Final-Rule-Home-Page-Items/FY2018-IPPS-Final-Rule-Regulations.htmlAccessed December 12th, 2017
  • AuffretVLefevreTVan BelleETemporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVIJ Am Coll Cardiol2017701425528662806
  • BabaliarosVDevireddyCLerakisSComparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysisJACC Cardiovasc Interv20147889890425086843
  • GutmannAKaierKSorgSAnalysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care SystemInt J Cardiol201517923123725464455
  • PoveroMPradelliLComparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in USFarmeconomia. Health Economics and Therapeutic Pathways20151637786
  • PoveroMPradelliLComparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysisHealth Economics and Therapeutic Pathways201516Supp1 1316
  • Kardaś-SłomaLLucetJCPerozzielloAUniversal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysisBMJ Open2017711e017402
  • BertiEFortunaDBartoliSI costi di ricovero e follow-up delle procedure di sostituzione valvolare aortica per via percutanea e cardiochirurgica a confronto: analisi secondo le prospettive del Sistema Sanitario Regionale e dell’OspedaleG Ital Cardiol201617Suppl 1S22S30
  • FairbairnTAMeadsDMHulmeCThe cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative riskHeart2013991391492023696198
  • ThompsonKTaylorCFordeKHammondNThe evolution of Australian intensive care and its related costs: A narrative reviewAust Crit Care201831532533028967466
  • MurphyJCHansenPSBhindiRFigtreeGANelsonGIWardMRCost benefit for assessment of intermediate coronary stenosis with fractional flow reserve in public and private sectors in AustraliaHeart Lung Circ201423980781024841388
  • WalshTSStanworthSBoydJThe Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-upHealth Technol Assess201721621118
  • RayMJBrownKFBurrowsCAO’BrienMFEconomic evaluation of high-dose and low-dose Aprotinin therapy during cardiopulmonary bypassAnn Thorac Surg199968394094510509988
  • The Economic Impact of End-Stage Kidney Disease in Australia – Projections to 2020 [webpage on the Internet]Kidney Health Australia (KHA)2010 Available from: http://kidney.org.au/cms_uploads/docs/kha-economic-impact-of-eskd-in-australia-projections-2020.pdfAccessed December 12th, 2017
  • GadaHKapadiaSRTuzcuEMSvenssonLGMarwickTHMurat TuzcuEMarkov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patientsAm J Cardiol201210991326133322335853
  • FattoreGTorbicaASusiAThe social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness studyBMC Neurol20121213723150894
  • DeweyHMThriftAGMihalopoulosCCost of Stroke in Australia From a Societal PerspectiveStroke2001322409241611588334
  • DenizHBCaroJJWardAMollerJMalikFEconomic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in ItalyJ Cardiovasc Med2008914350
  • PalmerAJRozeSValentineWJThe CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-makingCurr Med Res Opin200420Suppl 1S5S26
  • IcksAHaastertBGandjourACosts of dialysis--a regional population-based analysisNephrol Dial Transplant20102551647165220008830
  • RayJAValentineWJSecnikKReview of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and SpainCurr Med Res Opin200521101617162916238902
  • RoggeriARoggeriDPZocchettiCHealthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysisJ Nephrol201730226326927165160
  • LiBCairnsJAFotheringhamJUnderstanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffsNephrol Dial Transplant201530101726173426071229
  • HowardKSalkeldGWhiteSThe cost-effectiveness of increasing kidney transplantation and home-based dialysisNephrology200914112313219207859
  • MercaldiCJSiuKSanderSDLong-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial FibrillationCardiol Res Pract2012201264546923082276
  • Penaloza-RamosMCJowettSBartonPCost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP studyEur J Prev Cardiol201623151590159827226338
  • RinfretSCohenDJLamasGACost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunctionCirculation2005111216517215630030
  • WiegandUKPotratzJBodeFCost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?Eur Heart J200122217418011161919
  • FagnaniFLitzlerPYEltchaninofHCost-effectiveness of trans-catheter aortic valve implantation in high-risk patients with symptomatic aortic valve stenosis in FranceValue Health2009127A328
  • EdwardsSJKarnerCTrevorNDual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluationHealth Technology Assessment (HTA)201519651210
  • TaylorCJMonahanMRoalfeAKBartonPIlesRHobbsFDRThe REFER (REFer for EchocaRdiogram) study: a prospective validation and health economic analysis of a clinical decision rule, NT-proBNP or their combination in the diagnosis of heart failure in primary careEME201743156
  • Bravo VergelYPalmerSAsseburgCIs primary angioplasty cost effective in the UK? Results of a comprehensive decision analysisHeart200793101238124317717037
  • McCarthyFHSavinoDCBrownCRCost and contribution margin of transcatheter versus surgical aortic valve replacementJ Thorac Cardiovasc Surg201715461872188028712581
  • CohenJDwebpage on the InternetCost-effectiveness of transcatheter vs. surgical aortic valve replacement in intermediate risk patientsTCT 2017Denver, COOctober 31 2017 Available from: https://www.acc.org/~/media/Clinical/PDF-Files/Approved-PDFs/2017/10/24/TCT17_Presentation_Slides/Tue_Oct31/PARTNER-2A-SAPIEN-3-Cost-Effectiveness-TCT-2017.pdfAccessed December 12th, 2017